HEADER OXIDOREDUCTASE 17-APR-00 1EUP TITLE X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE TITLE 2 BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450ERYF; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROPOLYSPORA ERYTHRAEA; SOURCE 3 ORGANISM_TAXID: 1836 KEYWDS CYTOCHROME P450, STEROID, ANDROSTENEDIONE, CYTOCHROME P450ERYF, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.CUPP-VICKERY,R.ANDERSON,Z.HATZIRIS REVDAT 5 07-FEB-24 1EUP 1 REMARK LINK REVDAT 4 31-JAN-18 1EUP 1 REMARK REVDAT 3 24-FEB-09 1EUP 1 VERSN REVDAT 2 01-APR-03 1EUP 1 JRNL REVDAT 1 28-APR-00 1EUP 0 SPRSDE 17-APR-00 1EUP 1EH0 JRNL AUTH J.CUPP-VICKERY,R.ANDERSON,Z.HATZIRIS JRNL TITL CRYSTAL STRUCTURES OF LIGAND COMPLEXES OF P450ERYF JRNL TITL 2 EXHIBITING HOMOTROPIC COOPERATIVITY. JRNL REF PROC.NATL.ACAD.SCI.USA V. 97 3050 2000 JRNL REFN ISSN 0027-8424 JRNL PMID 10716705 JRNL DOI 10.1073/PNAS.050406897 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 23549 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3139 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 331 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EUP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-APR-00. REMARK 100 THE DEPOSITION ID IS D_1000010909. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JAN-99 REMARK 200 TEMPERATURE (KELVIN) : 22 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23549 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000 NAAC TRIS, PH 8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 22K, TEMPERATURE 295.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.07700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.71500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.55700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.71500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.07700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.55700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 3 96.04 63.29 REMARK 500 HIS A 13 -9.07 -145.94 REMARK 500 ALA A 27 109.04 -163.84 REMARK 500 PRO A 66 104.41 -49.25 REMARK 500 ASP A 134 14.29 -160.30 REMARK 500 PHE A 144 -71.24 -151.30 REMARK 500 GLU A 161 -75.95 -22.22 REMARK 500 ALA A 163 -47.55 -167.79 REMARK 500 GLN A 346 132.25 -170.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 410 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 351 SG REMARK 620 2 HEM A 410 NA 100.1 REMARK 620 3 HEM A 410 NB 88.8 87.8 REMARK 620 4 HEM A 410 NC 92.4 167.5 92.1 REMARK 620 5 HEM A 410 ND 104.6 90.2 166.6 87.1 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ASD A 451 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ASD A 452 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EGY RELATED DB: PDB REMARK 900 P450ERYF WITH 9-AMINOPHENANTHRENE BOUND DBREF 1EUP A 2 404 UNP Q00441 CPXJ_SACER 1 403 SEQRES 1 A 403 ALA THR VAL PRO ASP LEU GLU SER ASP SER PHE HIS VAL SEQRES 2 A 403 ASP TRP TYR SER THR TYR ALA GLU LEU ARG GLU THR ALA SEQRES 3 A 403 PRO VAL THR PRO VAL ARG PHE LEU GLY GLN ASP ALA TRP SEQRES 4 A 403 LEU VAL THR GLY TYR ASP GLU ALA LYS ALA ALA LEU SER SEQRES 5 A 403 ASP LEU ARG LEU SER SER ASP PRO LYS LYS LYS TYR PRO SEQRES 6 A 403 GLY VAL GLU VAL GLU PHE PRO ALA TYR LEU GLY PHE PRO SEQRES 7 A 403 GLU ASP VAL ARG ASN TYR PHE ALA THR ASN MET GLY THR SEQRES 8 A 403 SER ASP PRO PRO THR HIS THR ARG LEU ARG LYS LEU VAL SEQRES 9 A 403 SER GLN GLU PHE THR VAL ARG ARG VAL GLU ALA MET ARG SEQRES 10 A 403 PRO ARG VAL GLU GLN ILE THR ALA GLU LEU LEU ASP GLU SEQRES 11 A 403 VAL GLY ASP SER GLY VAL VAL ASP ILE VAL ASP ARG PHE SEQRES 12 A 403 ALA HIS PRO LEU PRO ILE LYS VAL ILE CYS GLU LEU LEU SEQRES 13 A 403 GLY VAL ASP GLU ALA ALA ARG GLY ALA PHE GLY ARG TRP SEQRES 14 A 403 SER SER GLU ILE LEU VAL MET ASP PRO GLU ARG ALA GLU SEQRES 15 A 403 GLN ARG GLY GLN ALA ALA ARG GLU VAL VAL ASN PHE ILE SEQRES 16 A 403 LEU ASP LEU VAL GLU ARG ARG ARG THR GLU PRO GLY ASP SEQRES 17 A 403 ASP LEU LEU SER ALA LEU ILE SER VAL GLN ASP ASP ASP SEQRES 18 A 403 ASP GLY ARG LEU SER ALA ASP GLU LEU THR SER ILE ALA SEQRES 19 A 403 LEU VAL LEU LEU LEU ALA GLY PHE GLU ALA SER VAL SER SEQRES 20 A 403 LEU ILE GLY ILE GLY THR TYR LEU LEU LEU THR HIS PRO SEQRES 21 A 403 ASP GLN LEU ALA LEU VAL ARG ALA ASP PRO SER ALA LEU SEQRES 22 A 403 PRO ASN ALA VAL GLU GLU ILE LEU ARG TYR ILE ALA PRO SEQRES 23 A 403 PRO GLU THR THR THR ARG PHE ALA ALA GLU GLU VAL GLU SEQRES 24 A 403 ILE GLY GLY VAL ALA ILE PRO GLN TYR SER THR VAL LEU SEQRES 25 A 403 VAL ALA ASN GLY ALA ALA ASN ARG ASP PRO SER GLN PHE SEQRES 26 A 403 PRO ASP PRO HIS ARG PHE ASP VAL THR ARG ASP THR ARG SEQRES 27 A 403 GLY HIS LEU SER PHE GLY GLN GLY ILE HIS PHE CYS MET SEQRES 28 A 403 GLY ARG PRO LEU ALA LYS LEU GLU GLY GLU VAL ALA LEU SEQRES 29 A 403 ARG ALA LEU PHE GLY ARG PHE PRO ALA LEU SER LEU GLY SEQRES 30 A 403 ILE ASP ALA ASP ASP VAL VAL TRP ARG ARG SER LEU LEU SEQRES 31 A 403 LEU ARG GLY ILE ASP HIS LEU PRO VAL ARG LEU ASP GLY HET HEM A 410 43 HET ASD A 451 21 HET ASD A 452 21 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM ASD 4-ANDROSTENE-3-17-DIONE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 ASD 2(C19 H26 O2) FORMUL 5 HOH *331(H2 O) HELIX 1 1 SER A 9 HIS A 13 5 5 HELIX 2 2 ASP A 15 ALA A 27 1 13 HELIX 3 3 GLY A 44 ASP A 54 1 11 HELIX 4 4 PHE A 72 LEU A 76 5 5 HELIX 5 5 PRO A 79 ALA A 87 1 9 HELIX 6 6 ASN A 89 SER A 93 5 5 HELIX 7 7 PRO A 96 GLN A 107 1 12 HELIX 8 8 THR A 110 ALA A 116 1 7 HELIX 9 9 MET A 117 GLY A 133 1 17 HELIX 10 10 ILE A 140 PHE A 144 1 5 HELIX 11 11 HIS A 146 GLY A 158 1 13 HELIX 12 12 GLY A 165 LEU A 175 1 11 HELIX 13 13 ASP A 178 GLU A 180 5 3 HELIX 14 14 ARG A 181 GLU A 206 1 26 HELIX 15 15 ASP A 210 VAL A 218 1 9 HELIX 16 16 SER A 227 HIS A 260 1 34 HELIX 17 17 HIS A 260 ASP A 270 1 11 HELIX 18 18 ALA A 273 ILE A 285 1 13 HELIX 19 19 ALA A 315 ASN A 320 1 6 HELIX 20 20 GLN A 346 PHE A 350 5 5 HELIX 21 21 GLY A 353 PHE A 372 1 20 HELIX 22 22 ASP A 380 VAL A 384 5 5 SHEET 1 A 5 VAL A 29 PHE A 34 0 SHEET 2 A 5 GLN A 37 VAL A 42 -1 O GLN A 37 N PHE A 34 SHEET 3 A 5 THR A 311 VAL A 314 1 O THR A 311 N TRP A 40 SHEET 4 A 5 THR A 291 ALA A 295 -1 O THR A 291 N VAL A 314 SHEET 5 A 5 LEU A 57 SER A 58 -1 N SER A 58 O PHE A 294 SHEET 1 B 3 VAL A 137 ASP A 139 0 SHEET 2 B 3 PRO A 399 ARG A 401 -1 N VAL A 400 O VAL A 138 SHEET 3 B 3 SER A 376 LEU A 377 -1 O SER A 376 N ARG A 401 SHEET 1 C 2 VAL A 299 ILE A 301 0 SHEET 2 C 2 VAL A 304 ILE A 306 -1 O VAL A 304 N ILE A 301 LINK SG CYS A 351 FE HEM A 410 1555 1555 2.19 CISPEP 1 PRO A 95 PRO A 96 0 -0.06 SITE 1 AC1 21 MET A 90 GLY A 91 HIS A 98 ARG A 102 SITE 2 AC1 21 PHE A 109 LEU A 238 ALA A 241 GLY A 242 SITE 3 AC1 21 ALA A 245 PRO A 288 THR A 291 ARG A 293 SITE 4 AC1 21 SER A 343 GLY A 345 HIS A 349 CYS A 351 SITE 5 AC1 21 GLY A 353 ALA A 357 ASD A 451 HOH A 502 SITE 6 AC1 21 HOH A 817 SITE 1 AC2 9 ASN A 89 GLY A 91 THR A 92 ALA A 241 SITE 2 AC2 9 GLU A 244 ALA A 245 LEU A 392 HEM A 410 SITE 3 AC2 9 ASD A 452 SITE 1 AC3 9 TYR A 75 PHE A 86 SER A 171 ILE A 174 SITE 2 AC3 9 LEU A 175 LEU A 240 GLU A 244 LEU A 391 SITE 3 AC3 9 ASD A 451 CRYST1 54.154 79.114 99.430 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018466 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012640 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010057 0.00000